Lead Product(s) : INE963
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
MMV Awards Project of the Year 2019 to Novartis for the Discovery of INE963
Details : INE963, approved as a preclinical candidate by MMV’s Expert Scientific Advisory Committee, the third clinical candidate that has come from NITD group. It is a exciting molecule with a number of desirable properties that could make it a potent weapon fo...
Product Name : INE963
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 13, 2020
Lead Product(s) : INE963
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
